Reports for LORAZEPAM
Ingredient
LORAZEPAM
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-12-01 | 2021-12-20 | 150252 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2022-04-01 | 2022-05-13 | 157698 |
| ATIVAN | 1MG | TABLET | Avoided shortage | 2017-12-06 | 2017-12-13 | 31935 |
| ATIVAN | 1MG | TABLET | Resolved | 2024-07-04 | 2024-11-25 | 232270 |
| ATIVAN | 2MG | TABLET | Resolved | 2024-07-04 | 2025-10-18 | 232288 |
| ATIVAN | 2MG | TABLET | Avoided shortage | 2017-11-06 | 2017-12-06 | 28375 |
| ATIVAN | 2MG | TABLET | Resolved | 2021-11-30 | 2022-02-01 | 150219 |
| ATIVAN | 2MG | TABLET | Resolved | 2022-09-26 | 2022-10-04 | 170189 |
| ATIVAN | 2MG | TABLET | Resolved | 2023-11-17 | 2024-10-03 | 210735 |
| ATIVAN | 1MG | TABLET | Resolved | 2021-01-18 | 2021-03-26 | 131898 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| ATIVAN | 1MG | TABLET | To be discontinued | 2025-10-17 | 2025-10-17 | 269846 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269826 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269840 |
| ATIVAN | 1MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269837 |
| ATIVAN | 0.5MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269831 |
| ATIVAN | 0.5MG | TABLET | To be discontinued | 2025-10-17 | 2025-10-17 | 269843 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 |